BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
57 results:

  • 1. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
    Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term outcomes with HLX01 (HanliKang
    Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
    BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circ_0058063 regulates cell vitality and proliferation in oesophageal squamous-cell carcinomas.
    Yang Y; Zhu B; Ning Z; Wang X; Li Z; Zhang C; Wen L
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23470. PubMed ID: 37477183
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of Body Mass Index With Outcomes Among Patients With head and neck cancer Treated With Chemoradiotherapy.
    Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
    JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer.
    Rodriguez Schaap PM; Lin JF; Metman MJH; Dreijerink KMA; Links TP; Bonjer HJ; Nieveen van Dijkum EJM; Dickhoff C; Kruijff S; Engelsman AF
    J Natl Cancer Inst; 2023 Sep; 115(9):1071-1076. PubMed ID: 37267155
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PD-1/PD-L1 based immunochemotherapy versus chemotherapy alone for advanced esophageal squamous cell carcinoma: A meta-analysis focus on PD-L1 expression level.
    Jin Z; Wang J; Sun J; Zhu C; Zhang J; Zhang B
    Cancer Rep (Hoboken); 2023 Jul; 6(7):e1794. PubMed ID: 37199321
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long-term Outcomes of Ultrasound-guided Thermal Ablation for the treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study.
    Yan L; Liu Y; Li W; Zhu Y; Wang J; Zhang M; Tang J; Che Y; Wang H; Wang S; Luo Y
    Ann Surg; 2023 May; 277(5):846-853. PubMed ID: 36727947
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Palliative Care Effects on Survival in Glioblastoma: Who Receives Palliative Care?
    Pando A; Patel AM; Choudhry HS; Eloy JA; Goldstein IM; Liu JK
    World Neurosurg; 2023 Feb; 170():e847-e857. PubMed ID: 36481442
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma.
    Motoyama S; Hosaka M; Kamei T; Ueno M; Watanabe M; Ohkura YU; Mine S; Tanabe S; Toyokawa T; Wakita A; Nishikawa K; Ninomiya I; Fujita K; Kanda M; Hirai M; Hoshi M; Chiu SW; Takata M; Yamaguchi T; Miura M
    Anticancer Res; 2022 Dec; 42(12):6105-6112. PubMed ID: 36456128
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association between thyroid cancer and cardiovascular disease risk: a nationwide observation study.
    Tsai MC; Hsieh CT; Hsu HY; Yeh TL; Lee WC; Chiang CJ; Hsiao BY; Jhuang JR; Tsai WH; Cheng SP; Chou CL; Lee CC; Liu SC; Tseng PJ; Chien KL
    Sci Rep; 2022 Nov; 12(1):18438. PubMed ID: 36323730
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Minimally invasive enucleation for benign and low-grade malignant pancreatic tumors: an analysis of 60 cases].
    Liu MQ; Liu WS; Li Z; Zhuo QF; Ji SR; Xu WY; Shi YH; Yu XJ; Xu XW
    Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):674-679. PubMed ID: 35775260
    [No Abstract]    [Full Text] [Related]  

  • 12. First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.
    Kojima T; Hara H; Tsuji A; Yasui H; Muro K; Satoh T; Ogata T; Ishihara R; Goto M; Baba H; Nishina T; Han S; Sakata T; Yatsuzuka N; Doi T; Kato K
    Esophagus; 2022 Oct; 19(4):683-692. PubMed ID: 35668304
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of ischemic conditioning on head and neck free flap oxygenation: a randomized controlled trial.
    Min SH; Choe SH; Kim WS; Ahn SH; Cho YJ
    Sci Rep; 2022 May; 12(1):8130. PubMed ID: 35581399
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
    Waguespack SG; Drilon A; Lin JJ; Brose MS; McDermott R; Almubarak M; Bauman J; Casanova M; Krishnamurthy A; Kummar S; Leyvraz S; Oh DY; Park K; Sohal D; Sherman E; Norenberg R; Silvertown JD; Brega N; Hong DS; Cabanillas ME
    Eur J Endocrinol; 2022 Apr; 186(6):631-643. PubMed ID: 35333737
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
    Zhang X; Gari A; Li M; Chen J; Qu C; Zhang L; Chen J
    J Transl Med; 2022 Feb; 20(1):61. PubMed ID: 35109887
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Novel Autophagy-Related Prognostic Risk Model and a Nomogram for Survival Prediction of Oral cancer Patients.
    Fei H; Chen X
    Biomed Res Int; 2022; 2022():2067540. PubMed ID: 35036428
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Microwave ablation of autonomously functioning thyroid nodules: a comparative study with radioactive iodine therapy on the functional treatment success.
    Ertürk MS; Cekic B; Celik M; Demiray Uguz I
    Endokrynol Pol; 2021; 72(2):120-125. PubMed ID: 33619707
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany.
    Morkramer L; Geitner M; Boeger D; Buentzel J; Kaftan H; Mueller AH; Ernst T; Guntinas-Lichius O
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2625-2635. PubMed ID: 33517469
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Margin Positivity and Survival Outcomes: A Review of 14,471 Patients with 1-cm to 4-cm Papillary Thyroid Carcinoma.
    Khan ZF; Kutlu O; Picado O; Lew JI
    J Am Coll Surg; 2021 Apr; 232(4):545-550. PubMed ID: 33421566
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical and prognostic effects of adjuvant therapy on less advanced esophageal squamous cell carcinoma patients.
    Shang QX; Yang YS; Yuan Y; Gu YM; Zhang HL; Ji AF; Chen LQ
    Ann Palliat Med; 2020 May; 9(3):681-699. PubMed ID: 32389011
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.